Skip to content

Study · Case report or series · n = 18 · 2007

1 result

Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors.

Kane GC, Hoehn SM, Behrenbeck TR, Mulvagh SL

Archives of internal medicine1 Oct 2007Cited by 70 (Europe PMC)

PMID17923598 (opens in a new tab)DOI10.1001/archinte.167.18.1977 (opens in a new tab)PepBankPUB-17923598
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In patients with benzocaine-induced methemoglobinemia after TEE, symptoms and signs resolved after methylene blue treatment.

    In plain wordsIn patients with benzocaine-induced methemoglobinemia after TEE, symptoms and signs resolved after methylene blue treatment.

    Peptide
    Methylene blue
    Outcome
    DecreaseResolution of methemoglobinemia symptoms and signs
    Study

    n = 18

    Outcome group
    Adverse events · Whole body
    Studied dose
    1.3 +/- 0.4 mg/kgAs given in this study (human).

    Source sentences

    Summary
    Eighteen of 19 patients received methylene blue (mean +/- SD dose, 1.3 +/- 0.4 mg/kg of body weight), with resolution of symptoms and signs.
    1 context sentence
    Summary · context
    All cases of methemoglobinemia complicating TEE at our institution (from January 1, 1999, to July 1, 2006) were identified by a comprehensive review of medical records and echocardiography and pharmacy databases.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.